Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael D Angelo

Diagnostic Radiology Baltimore, MD Medical Doctor

NPI 1457493652 CMS profile 111726

600 N Wolfe St, Baltimore, MD 21287

Open in the dashboard

General payments

$26,004

64 records reported · program years 2019–2025

Research payments

$16,751

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$48,895 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Michael D Angelo of Baltimore, MD is reported in the CMS Open Payments database as having received $26,004 across 64 general payments and $16,751 in research payments paid to them. Separately, studies naming them as principal investigator received $48,895 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $333 5
2025 Research $1,856 2
2024 General $115 4
2023 General $166 2
2022 General $241 3
2022 Research $14,895 1
2021 General $16,288 31
2020 General $8,784 14
2019 General $77 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael D Angelo
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Michael D Angelo were reported at $333. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Michael D Angelo Diagnostic Radiology median Middle half National median
2019 $77 $108 $29–$318 $163
2020 $8,784 $65 $21–$252 $114
2021 $16,288 $92 $24–$292 $132
2022 $241 $104 $29–$294 $149
2023 $166 $110 $29–$337 $160
2024 $115 $113 $30–$356 $164
2025 $333 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $23,940 36 payments
  2. Inari Medical, Inc. $828 9 payments
  3. Argon Medical Devices, Inc. $425 3 payments
  4. Stryker Corporation $266 3 payments
  5. Medtronic, Inc. $169 2 payments
  6. Bard Peripheral Vascular, Inc. $133 1 payment
  7. Siemens Medical Solutions USA, Inc. $75 1 payment
  8. Sirtex Medical Inc $33 1 payment
  9. Bayer HealthCare Pharmaceuticals Inc. $31 2 payments
  10. Boston Scientific Corporation $25 1 payment
  11. Other $78 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $23,940 36 payments
  2. Food and Beverage $2,064 28 payments
Products named General payments · program years 2019–2025
  1. KEYTRUDA $14,955 18 payments
  2. WELIREG $4,035 9 payments
  3. FlowTriever Venous Thrombectomy $499 4 payments
  4. ClotTriever $499 4 payments
  5. BIOPINCE $400 1 payment
  6. FLOWTRIEVER CATHETER, S $329 5 payments
  7. CT THROMBECTOMY SYSTEM KIT $329 5 payments
  8. FLOWTRIEVER Inari Medical $266 3 payments
  9. ELLIPSYS VASCULAR ACCESS SYSTEM $169 2 payments
  10. ONCOZENE $75 1 payment
  11. Other $242 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Celltrion, Inc. $14,895 1 payment
  2. E.R. Squibb & Sons, L.L.C. $1,395 1 payment
  3. GlaxoSmithKline, LLC. $461 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

19

Median for Diagnostic Radiology: 24

Drug cost

$8

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Metoprolol Tartrate Generic 19 $8

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 211 billing codes

Paid by Medicare

$197,322

Of which drugs: $689

Medicare patients

2,153

Average age 75

Services billed

10,119

1,446 women, 707 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Ischemic heart disease 41%
Diabetes 36%
Chronic kidney disease 28%
Heart failure 27%
Depression 27%
Atrial fibrillation 26%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 55 5,790 $613

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

67 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record